SBS says Insulet investors may join securities fraud suit over Pod manufacturing claims

By Atlas Watchline Staff · Legal · August 17, 2026

Schall Brown & Schwartz LLP says investors who bought Insulet shares during a stated class period may be eligible to join a securities fraud lawsuit over alleged misleading statements and manufacturing control defects.

Schall Brown & Schwartz LLP said Monday that investors who bought Insulet Corp. shares during a stated class period may be eligible to join a securities fraud class action over alleged false and misleading statements and manufacturing control defects.

The firm’s investor alert concerns Insulet, which trades on Nasdaq under the ticker PODD. It says the proposed class period runs from Feb. 21, 2025, through May 26, 2026.

The complaint seeks to recover alleged losses tied to the company’s disclosures about its manufacturing processes and a March 2026 medical device correction. The release says the case alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.

According to the alert, the complaint alleges Insulet made false and misleading statements to the market, had defective controls over its manufacturing processes, and faced increased risks of safety violations because of those deficiencies. The release also says the company’s March 2026 medical device correction affected more Pod products than Insulet had claimed.

The alert says the class has not yet been certified. It also says that until certification occurs, investors are not represented by an attorney and can remain absent class members if they take no action.

The firm told shareholders who purchased PODD during the class period that they may be entitled to compensation without paying out-of-pocket fees or costs. It asked investors to contact Brian Schall and David Schwartz of Schall Brown & Schwartz to discuss their rights or possible lead-plaintiff participation.

The release lists the firm’s address as 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, with phone number 310-301-3335. It also gives the firm’s website as www.schallfirm.com and the email address [email protected].

The alert says the class action remains in the litigation stage and that investors who do nothing can stay in the case as absent class members if the class is certified later.

Sources

• PR Newswire investor alert from Schall Brown & Schwartz LLP

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.

This is the AMP version of the article. Read the full article on Atlas Watchline.